Myfortic 180 mg/1 (Mycophenolic Acid TABLET, DELAYED RELEASE) 180 mg/1

Myfortic 180 mg is a delayed-release tablet containing mycophenolic acid, used to prevent organ rejection post-transplant. It is commonly prescribed for kidney transplant patients.

Strength

180 mg/1

Pack Size

120 TABLET, DELAYED RELEASE in 1 BOTTLE (0078-0385-66)

Manufacturer / TM Owner

Novartis Pharmaceuticals Corporation

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Myfortic 180 mg is primarily used to prevent rejection of transplanted organs, particularly kidneys. It works by suppressing the immune system to help the body accept the new organ. This medication is often prescribed in combination with other immunosuppressants. Patients may wonder, 'What is Myfortic used for?' It is specifically designed to aid in the acceptance of transplanted organs.

Side Effects

Common effects of Myfortic 180 mg may include gastrointestinal issues such as diarrhea, nausea, and vomiting. Some patients may also experience fatigue or an increased risk of infections due to its immune-suppressing properties. It is important to monitor for any unusual symptoms and consult a healthcare provider if they persist or worsen.

Precautions & Warnings

Myfortic 180 mg should be handled with care, as it can increase the risk of infections and other complications. It is essential to follow the prescribed dosage and administration instructions closely. Patients should avoid activities that may increase the risk of injury or infection while taking this medication. Regular blood tests may be required to monitor the body's response to the drug.

Avoid Interactions

Myfortic 180 mg may interact with other medications, including antacids containing magnesium or aluminum, which can reduce its effectiveness. It is also important to avoid taking it with cholesterol-lowering drugs like cholestyramine. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions.

Frequently Asked Questions

Myfortic 180 mg is used to prevent rejection of transplanted organs, particularly kidneys, by suppressing the immune system.

Myfortic 180 mg should be taken orally, typically twice a day, with a full glass of water. It is important to follow the specific instructions provided by your healthcare provider.

Common side effects include gastrointestinal issues such as diarrhea, nausea, and vomiting, as well as fatigue and an increased risk of infections.

Myfortic 180 mg may interact with certain medications, so it is important to consult your healthcare provider before taking it with other drugs.

Long-term use of Myfortic 180 mg should be monitored by a healthcare provider to manage potential side effects and interactions.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.